A Randomized, Double Blind, Placebo-Controlled, Single Dose Study to Assess The Safety and Efficacy of Intramuscular Sebacoyl Dinalbuphine Ester (SDE) for Post-Hemorrhoidectomy Pain Management

Trial Profile

A Randomized, Double Blind, Placebo-Controlled, Single Dose Study to Assess The Safety and Efficacy of Intramuscular Sebacoyl Dinalbuphine Ester (SDE) for Post-Hemorrhoidectomy Pain Management

Completed
Phase of Trial: Phase II/III

Latest Information Update: 06 Jul 2015

At a glance

  • Drugs LT 1001 (Primary)
  • Indications Pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Lumosa Therapeutics
  • Most Recent Events

    • 01 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov .
    • 13 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top